SAB Biotherapeutics (SABSW) had the highest return on July 1, 2024 by a US stock, returning 54.1%.

ASSET	DATE	% RETURN
SAB Biotherapeutics (SABSW)	7/1/2024	54.13%
Oxbridge Re Holdings Equity Warrant (OXBRW)	7/1/2024	50%
NRx Pharmaceuticals (NRXPW)	7/1/2024	49.12%
Nuvve (NVVEW)	7/1/2024	44.83%
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW)	7/1/2024	39.32%
SHF (SHFSW)	7/1/2024	36.91%
Ocean Power Technologies (OPTT)	7/1/2024	36.06%
TROOPS (TROO)	7/1/2024	32.67%
Scienture (SCNX)	7/1/2024	31.91%
New Horizon Aircraft (HOVRW)	7/1/2024	30.37%
Cardio Diagnostics (CDIOW)	7/1/2024	27.33%
NLS Pharmaceutics (NLSPW)	7/1/2024	26.67%
POET Technologies (POET)	7/1/2024	25.91%
Diana Shipping Inc WT (DSX.WT)	7/1/2024	25%
Osisko Development Corp Warrant expiring 5/27/2027 (ODVWZ)	7/1/2024	25%
SaverOne 2014 Ltd Warrant (SVREW)	7/1/2024	24.8%
CuriosityStream (CURIW)	7/1/2024	24.53%
Advantage Solutions (ADVWW)	7/1/2024	24.07%
Oncology Institute (TOIIW)	7/1/2024	23.81%
Applied DNA Sciences (APDN)	7/1/2024	20.44%
MicroCloud Hologram (HOLOW)	7/1/2024	19.78%
Cosmos Health (COSM)	7/1/2024	19.57%
Contineum Therapeutics, Inc Class A Common Stock (CTNM)	7/1/2024	19.39%
Aurora Innovation (AUROW)	7/1/2024	19.31%
Azitra (AZTR)	7/1/2024	19.3%